Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
An Ipsen-commissioned survey has
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

OIG: Jury still out on impacts of vertical consolidation in Part D

Doximity inks partnerships with Aledade, Photon as it ramps up AI spending in 2026

Health system revenue heads increasingly turning their attention to patients' share of the bill

WTW: Employers aiming to bulk up AI use for health and benefits

Psychedelic Therapies Are Almost Here. The Infrastructure Isn't.

Drugmakers guard IP more tightly amid China competition

ACA exchange enrollment likely to decline by at least 17% this year: KFF

Turn Language Access into an Operational Advantage

Strengthening core CDO values for cell line development | Strengthening core CDO values for cell line development

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,

Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. | In this tracker, Fierce Pharma is recording the…

There’s a thing that happens in American healthcare.You've got these massive systems—pharma conglomerates, hospital networks,…

After doubling sales of its Biogen-partnered Alzheimer’s disease med Leqembi in its 2025 fiscal year, Eisai figures the crawl to…

As biologics have come to supersede small molecules in the biopharma industry’s pipeline, the mounting complexity behind the…